A detailed history of Cibc World Markets Corp transactions in Exact Sciences Corp stock. As of the latest transaction made, Cibc World Markets Corp holds 10,753 shares of EXAS stock, worth $679,159. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,753
Previous 9,788 9.86%
Holding current value
$679,159
Previous $413,000 77.24%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$42.43 - $70.83 $40,944 - $68,350
965 Added 9.86%
10,753 $732,000
Q2 2024

Aug 12, 2024

BUY
$41.33 - $74.26 $98,530 - $177,035
2,384 Added 32.2%
9,788 $413,000
Q1 2024

May 13, 2024

BUY
$56.27 - $73.77 $133,416 - $174,908
2,371 Added 47.11%
7,404 $511,000
Q4 2023

Feb 13, 2024

BUY
$59.06 - $75.72 $297,248 - $381,098
5,033 New
5,033 $372,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Cibc World Markets Corp Portfolio

Follow Cibc World Markets Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.